|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 3075 Riverwood Dr. |
Address2 |
|
City | Mt. Pleasant |
State | SC |
Zip Code | 29466 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401027897-51
|
||||||||
|
6. House ID# 422190005
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: James Edwards |
Date | 10/5/2022 4:58:45 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
STRONGER Patents Act
National Institute of Standards and Technology (NIST) proposed revisions to Rights to Inventions Made by Nonprofit Organizations and Small Business Firms under Government Grants, Contracts, and Cooperative Agreements and Licensing of Government-Owned Inventions (NIST Docket No. 201207-0327)
Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions
H.R. 3035/S. 1683 (Preventing Foreign Attempts to Erode Healthcare Innovation Act)
S. 1260 (Endless Frontier Act/United States Innovation and Competition Act) patent and intellectual property-related provisions and amendments
H.R. 4521 (America COMPETES Act)
H.R. 4792 (Countering Communist China Act) patent and intellectual property-related provisions
H.R. 1934 (Promoting United States International Leadership in 5G Act) standards development for standards-essential patents and innovation
Request for Information Regarding Patent Eligibility Jurisprudence Study (Docket No. PTO-P-2021-0032)
Bayh-Dole Act march-in misuse demands, including opposition to KEI petition to Health & Human Services to march in on Astellas patents on Xtandi
Bayh-Dole Act exceptions to statutory licensing provisions, unilaterally imposed by Energy Dept. requiring DOE review of all licensing agreements grantees negotiate in technology transfers
Patent & Trademark Office/PTAB discretion to institute or to deny trials before the Patent Trial and Appeal Board, pursuant to America Invents Act discretion; PTAB designation of precedential opinions, including the Fintiv doctrine to avoid duplicative litigation on the same patent claims in multiple forums
S. 2891 (Restoring the America Invents Act)
S. 2774 (Pride in Patent Ownership Act)
H.R. 5874 (Restoring Americas Leadership in Innovation Act)
Patent Trial and Appeal Board amicus re OpenSky Industries LLC v. VLSI Technology LLC (Case No. IPR2021-01064)
Draft Policy Statement on Licensing Negotiations and Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments (Docket No. ATR-2021-0001)
Patent eligibility/Section 101
Access to injunctive relief against patent infringers
Patent Trial and Appeal Board amicus re Palo Alto Networks Inc. v. Centripetal Networks Inc. (Case No. IPR2022-00182)
Patent Trial and Appeal Board amicus re OpenSky Industries LLC and Intel Corp.v. VLSI Technology LLC (Case No. IPR2021-01064) and Patent Quality Assurance LLC and Intel Corp. v. VLSI Technology LLC (Case No. IPR2021-01229)
S. 3772 (Defending American Courts Act)
S. 4417 (PTAB Reform Act)
S. 4430 (Interagency Patent Coordination and Improvement Act)
S. 4704 (Patent Examination and Quality Improvement Act)
S. 4734 (Patent Eligibility Restoration Act)
Request for Comments Regarding the Patent Subject Matter Eligibility Guidance (Docket No. PTO-P-2022-0026)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RES
16. Specific lobbying issues
H.R. 803 (Protecting America's Wilderness and Public Lands Act)
H.R. 859 (Protecting American Energy Jobs Act)
H.R. 3014 (30 x 30 Termination Act)
Executive Order 14008, Sec. 216 30 x 30 radical land grab program
EPA declaration requesting remand of the 2020 Navigable Waters Protection Rule
Unilateral executive action considered to effect administratively the essence of the Colorado Outdoor Recreation and Economy (CORE) Act and/or to misapply the Antiquities Act to take private property and/or restrict land use in Colorado
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S. 617/H.R. 1712 (Death Tax Repeal Act)
Tax provisions, namely capital gains confiscatory scheme, in Biden "American Families Plan
S.Con.Res. 14 (FY 2022 Budget Resolution) tax provisions for capital gains tax rate increase, taxing trusts, step up in basis repeal, taxing unrealized assets upon death (double death tax), 95 percent tax on those pharmaceuticals sold at fair market value
H.R. 5376 and subsequent versions of FY 2022 Budget Reconciliation tax provisions for capital gains tax rate increase, taxing trusts, step up in basis repeal, taxing unrealized assets upon death (double death tax), taxing unrealized capital gains, accelerated expiration of current estate and gift tax exemption levels, tax treatment changes of grantor retained annuity trusts (GRATS), valuation rules changes that ignore discounts from partial ownership or lack of control of an asset, 95 percent excise tax on those gross sales pharmaceuticals sold at fair market value
H.R. 5649 (BEAT CHINA Act)
Tax proposals, such as unrealized capital gains confiscatory wealth tax scheme, in Biden FY23 budget proposal, and the so-called Billionaire Minimum Income Tax (which kicks in at $100 million and well below that for certain family businesses and farms)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Price controls proposals regarding pharmaceuticals or other medical goods or services, including direct government price-setting of drugs in Medicare, Medicaid, and/or private insurance plans
H.R. 3 (Lower Drug Costs Now Act)
Interim Final Rule implementing a Most Favored Nation (MFN) Model for importing foreign price controls for certain Medicare Part B drugs (CMS-5528-IFC)
S.Con.Res. 14 (FY22 Budget Resolution) price control provisions to repeal noninterference clause in Medicare Parts C & D
H.R. 2884 (Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act)
H.R. 5237 (Reduced Costs and Continued Cures Act)
H.R. 5376 and subsequent versions of FY 2022 Budget Reconciliation price control provisions from H.R. 3, including repeal of noninterference clause in Medicare Parts C & D, and provisions expanding government-run health care, restrictions on private, Medicare, and Medicaid rates, coverage, and reimbursement, Medicare program changes reducing beneficiary choice, plan design, and competition
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Senate filibuster rules for the protection of minority rights to debate
S. 2428 (False Claims Act Amendments)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Antitrust
Consumer welfare standard
S. 225 (Competition and Antitrust Law Enforcement Reform Act)
H.R. 3460/S. 1787 (State Antitrust Enforcement Venue Act)
H.R. 3816/S. 2992 (American Choice and Innovation Online Act)
H.R. 3825 (Ending Platform Monopolies Act)
H.R. 3826/S. 3197 (Platform Competition and Opportunity Act)
H.R. 3843/S. 2039 (Merger Filing Fee Modernization Act)
S. 228 (TEAM Act)
H.R. 3849 (ACCESS Act)
H.R. 5639 (Foreign Merger Subsidy Disclosure Act)
House Judiciary Comm. Final Report on Investigation of Competition in Digital Markets
S. 1435/H.R. 2873 (Affordable Prescriptions for Patients Through Promoting Competition Act)
S. 1425/H.R. 2883 (Stop STALLING Act)
S. 1428/H.R. 2891 (Preserve Access to Affordable Generics)
S. 4258/H.R. 7839 (Competition and Transparency in Digital Advertising Act)
Federal Trade Commission motion to rescind the 2015 Statement of Enforcement Principles Regarding Unfair Methods of Competition (UMC) Under Section 5 of the FTC Act
Multilateral Pharmaceutical Merger Task Force (FTC Pharmaceutical Task Force, Project No. P212900)
Executive Order 14036 (Promoting Competition in the American Economy)
FTC Rescission of 1995 Policy Statement on Prior Approval and Prior Notice Provisions in Merger Cases
FTCs counting votes cast by a former commissioner
Nominations to Federal Trade Commission positions
FTC-Justice Dept. Request for Information on proposed Merger Enforcement Guidelines (FTC-2022-0003)
S. 2992 (American Innovation and Choice Online Act)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
EPA review of secondary National Ambient Air Quality Standards, pursuant to Clean Air Act, as backdoor Green New Deal elements
H.R. 5376 and subsequent versions of FY 2022 Budget Reconciliation Green New Deal-related provisions assaulting established, proven domestic energy sectors
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ECN
16. Specific lobbying issues
H.R. 5376 and subsequent versions of FY 2022 Budget Reconciliation inflationary provisions and effects
Various government interventions being considered such as excessive fiat money, subsidization, regulatory excesses that contribute to inflation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code COM
16. Specific lobbying issues
Nominations to Federal Communications Commission positions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Republican Study Committee FY23 budget Blueprint to Save America
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
James |
Edwards |
|
LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |